Biochemical properties and biological potential of Syzygium heyneanum with antiparkinson’s activity in paraquat induced rodent model

Saadullah, Malik and Tariq, Hafsa and Chauhdary, Zunera and Saleem, Uzma and Anwer Bukhari, Shazia and Sehar, Amna and Asif, Muhammad and Sethi, Aisha and Abd‐Elhakim, Yasmina (2024) Biochemical properties and biological potential of Syzygium heyneanum with antiparkinson’s activity in paraquat induced rodent model. PLOS ONE, 19 (3). e0298986. ISSN 1932-6203

[thumbnail of journal.pone.0298986.pdf] Text
journal.pone.0298986.pdf

Download (2MB)

Abstract

Syzygium heyneanum is a valuable source of flavonoids and phenols, known for their antioxidant and neuroprotective properties. This research aimed to explore the potential of Syzygium heyneanum ethanol extract (SHE) in countering Parkinson’s disease. The presence of phenols and flavonoids results in SHE displaying an IC50 value of 42.13 when assessed in the DPPH scavenging assay. Rats’ vital organs (lungs, heart, spleen, liver, and kidney) histopathology reveals little or almost no harmful effect. The study hypothesized that SHE possesses antioxidants that could mitigate Parkinson’s symptoms by influencing α-synuclein, acetylcholinesterase (AChE), TNF-α, and IL-1β. Both in silico and in vivo investigations were conducted. The Parkinson’s rat model was established using paraquat (1 mg/kg, i.p.), with rats divided into control, disease control, standard, and SHE-treated groups (150, 300, and 600 mg/kg) for 21 days. According to the ELISA statistics, the SHE treated group had lowers levels of IL-6 and TNF-α than the disease control group, which is a sign of neuroprotection. Behavioral and biochemical assessments were performed, alongside mRNA expression analyses using RT-PCR to assess SHE’s impact on α-synuclein, AChE, TNF-α, and interleukins in brain homogenates. Behavioral observations demonstrated dose-dependent improvements in rats treated with SHE (600 > 300 > 150 mg/kg). Antioxidant enzyme levels (catalase, superoxide dismutase, glutathione) were significantly restored, particularly at a high dose, with notable reduction in malondialdehyde. The high dose of SHE notably lowered acetylcholinesterase levels. qRT-PCR results indicated reduced mRNA expression of IL-1β, α-synuclein, TNF-α, and AChE in SHE-treated groups compared to disease controls, suggesting neuroprotection. In conclusion, this study highlights Syzygium heyneanum potential to alleviate Parkinson’s disease symptoms through its antioxidant and modulatory effects on relevant biomarkers.

Item Type: Article
Subjects: Article Archives > Biological Science
Depositing User: Unnamed user with email support@articlearchives.org
Date Deposited: 30 Mar 2024 12:14
Last Modified: 30 Mar 2024 12:14
URI: http://archive.paparesearch.co.in/id/eprint/2019

Actions (login required)

View Item
View Item